pharma_company
stringclasses 562
values | brand_name_en
stringlengths 19
232
| generic_name_en
stringlengths 21
250
| substance_name_en
stringclasses 983
values | atc_code_raw
stringclasses 778
values | anatomical_desc
stringclasses 14
values | therapeutic_desc
stringclasses 82
values | pharmacological_desc
stringclasses 181
values | subpharmacological_desc
stringclasses 365
values | chemical_desc
stringclasses 636
values |
---|---|---|---|---|---|---|---|---|---|
Tehran Chemie Pharmaceutical Co.
|
DIVAPOX TABLET, DELAYED RELEASE ORAL 250 mg
|
VALPROATE SEMISODIUM TABLET, DELAYED RELEASE ORAL 250 mg
|
VALPROATE SEMISODIUM
|
N03AG01
|
NERVOUS SYSTEM
|
ANTIEPILEPTICS
|
ANTIEPILEPTICS
|
Fatty acid derivatives
|
valproic acid
|
Tehran Chemie Pharmaceutical Co.
|
TRIMONTIL TABLET ORAL 100 mg
|
TRIMIPRAMINE (AS MALEATE) TABLET ORAL 100 mg
|
TRIMIPRAMINE (AS MALEATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
RELIDIN INJECTION PARENTERAL 25 mg/1mL 1 mL
|
PETHIDINE HYDROCHLORIDE INJECTION PARENTERAL 25 mg/1mL 1 mL
|
PETHIDINE HYDROCHLORIDE
|
N02AB02
|
NERVOUS SYSTEM
|
ANALGESICS
|
OPIOIDS
|
Phenylpiperidine derivatives
|
pethidine
|
Sajad Daru Shargh
|
CRESTOSAD TABLET ORAL 20 mg
|
ROSUVASTATIN (AS CALCIUM) TABLET ORAL 20 mg
|
ROSUVASTATIN (AS CALCIUM)
|
C10AA07
|
CARDIOVASCULAR SYSTEM
|
LIPID MODIFYING AGENTS
|
LIPID MODIFYING AGENTS, PLAIN
|
HMG CoA reductase inhibitors
|
rosuvastatin
|
Hakim Pharmaceutical Co.
|
MEFENAMIC ACID-HAKIM CAPSULE ORAL 250 mg
|
MEFENAMIC ACID CAPSULE ORAL 250 mg
|
MEFENAMIC ACID
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Razak Labratories
|
DOXYCYCLINE CAPSULE ORAL 100 mg
|
DOXYCYCLINE (AS MONOHYDRATE) CAPSULE ORAL 100 mg
|
DOXYCYCLINE (AS MONOHYDRATE)
|
J01AA02
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
TETRACYCLINES
|
Tetracyclines
|
doxycycline
|
Hakim Pharmaceutical Co.
|
METOCLOPRAMIDE-HAKIM TABLET ORAL 10 mg
|
METOCLOPRAMIDE HYDROCHLORIDE TABLET ORAL 10 mg
|
METOCLOPRAMIDE HYDROCHLORIDE
|
A03FA01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
PROPULSIVES
|
Propulsives
|
metoclopramide
|
Chemidarou
|
PROSTAM CAPSULE, EXTENDED RELEASE ORAL 0.4 mg
|
TAMSULOSIN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE ORAL 0.4 mg
|
TAMSULOSIN HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
ADOVAN TABLET ORAL 160 mg
|
VALSARTAN TABLET ORAL 160 mg
|
VALSARTAN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Daru
|
TRANEXAMIC ACID CAPSULE ORAL 250 mg
|
TRANEXAMIC ACID CAPSULE ORAL 250 mg
|
TRANEXAMIC ACID
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
DICYCLOMINE HYDROCHLORIDE TABLET ORAL 10 mg
|
DICYCLOMINE HYDROCHLORIDE TABLET ORAL 10 mg
|
DICYCLOMINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
ESTRADIOL VALERATE TABLET ORAL 2 mg
|
ESTRADIOL VALERATE TABLET ORAL 2 mg
|
ESTRADIOL VALERATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Daana Pharma
|
TEEN COLD CAPSULE, LIQUID FILLED ORAL 250 mg/12.5 mg/5 mg
|
ADULT COLD PREPARATIONS (4-9) CAPSULE, LIQUID FILLED ORAL 250 mg/12.5 mg/5 mg
|
ADULT COLD PREPARATIONS (4-9)
|
R05X
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
OTHER COLD PREPARATIONS
| null | null |
Tehran Darou Pharmaceutical Co.
|
VASARAN TABLET ORAL 160 mg
|
VALSARTAN TABLET ORAL 160 mg
|
VALSARTAN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
PENTOXIFYLLINE TABLET, EXTENDED RELEASE ORAL 400 mg
|
PENTOXIFYLLINE TABLET, EXTENDED RELEASE ORAL 400 mg
|
PENTOXIFYLLINE
|
C04AD03
|
CARDIOVASCULAR SYSTEM
|
PERIPHERAL VASODILATORS
|
PERIPHERAL VASODILATORS
|
Purine derivatives
|
pentoxifylline
|
Jalinous Pharmaceutical Co.
|
ACETAMINOPHEN-JALINOUS TABLET ORAL 325 mg
|
ACETAMINOPHEN TABLET ORAL 325 mg
|
ACETAMINOPHEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Raha Pharmaceutical Isfahan Company
|
ALEROPAT SPRAY NASAL 0.6 % 20 mL
|
OLOPATADINE HYDROCHLORIDE SPRAY NASAL 0.6 % 20 mL
|
OLOPATADINE HYDROCHLORIDE
|
R01AC08
|
RESPIRATORY SYSTEM
|
NASAL PREPARATIONS
|
DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
|
Antiallergic agents, excl. corticosteroids
|
olopatadine
|
Pharmachemie
|
BISOPROLOL TABLET ORAL 2.5 mg
|
BISOPROLOL FUMARATE TABLET ORAL 2.5 mg
|
BISOPROLOL FUMARATE
|
C07AB07
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
bisoprolol
|
Aburaihan Pharmaceutical Co
|
MEZALON SUPPOSITORY RECTAL 500 mg
|
MESALAZINE SUPPOSITORY RECTAL 500 mg
|
MESALAZINE
|
A07EC02
|
ALIMENTARY TRACT AND METABOLISM
|
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
|
INTESTINAL ANTIINFLAMMATORY AGENTS
|
Aminosalicylic acid and similar agents
|
mesalazine
|
Tehran Chemie Pharmaceutical Co.
|
HYPOTAZON TABLET ORAL 30 mg
|
PIOGLITAZONE TABLET ORAL 30 mg
|
PIOGLITAZONE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Tehran Chemie Pharmaceutical Co.
|
PARANOPAIN TABLET ORAL 300 mg/20 mg
|
ACETAMINOPHEN / CODEINE PHOSPHATE TABLET ORAL 300 mg/20 mg
|
ACETAMINOPHEN / CODEINE PHOSPHATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.9 % 1000 mL
|
SODIUM CHLORIDE INJECTION, SOLUTION PARENTERAL 0.9 % 1000 mL
|
SODIUM CHLORIDE
|
B05XA03
|
BLOOD AND BLOOD FORMING ORGANS
|
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
|
I.V. SOLUTION ADDITIVES
|
Electrolyte solutions
|
sodium chloride
|
zist Arvand Pharmed
|
PAGLIMET TABLET ORAL 5 mg/500 mg
|
EMPAGLIFLOZIN / METFORMIN HYDROCHLORIDE TABLET ORAL 5 mg/500 mg
|
EMPAGLIFLOZIN / METFORMIN HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
IBUKIM TABLET ORAL 400 mg
|
IBUPROFEN TABLET ORAL 400 mg
|
IBUPROFEN
|
M01AE01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Propionic acid derivatives
|
ibuprofen
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
SILERECT TABLET ORAL 100 mg
|
SILDENAFIL (AS CITRATE) TABLET ORAL 100 mg
|
SILDENAFIL (AS CITRATE)
|
G04BE03
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
UROLOGICALS
|
UROLOGICALS
|
Drugs used in erectile dysfunction
|
sildenafil
|
Amin Pharmaceutical Co.
|
AMIZOLE TABLET ORAL 500 mg
|
METRONIDAZOLE TABLET ORAL 500 mg
|
METRONIDAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Tehran Darou Pharmaceutical Co.
|
GRIPHEN ADULT TABLET ORAL 325 mg/5 mg/2 mg
|
ADULT COLD PREPARATIONS (4-3) TABLET ORAL 325 mg/5 mg/2 mg
|
ADULT COLD PREPARATIONS (4-3)
|
R05X
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
OTHER COLD PREPARATIONS
| null | null |
Octapharma
|
OCTAGAM INJECTION INTRAVENOUS 50 mg/1mL 100 g
|
IMMUNE GLOBULIN INJECTION INTRAVENOUS 50 mg/1mL 100 mL
|
IMMUNE GLOBULIN
|
J06BA02
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
IMMUNE SERA AND IMMUNOGLOBULINS
|
IMMUNOGLOBULINS
|
Immunoglobulins, normal human
|
immunoglobulins, normal human, for intravascular adm.
|
Salutas Pharma Gmbh
|
KETOF SYRUP ORAL 1 mg/5mL 100 mg
|
KETOTIFEN SYRUP ORAL 1 mg/5mL 100 mL
|
KETOTIFEN
|
R06AX17
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Other antihistamines for systemic use
|
ketotifen
|
Zagros Pharmed Pars Pharmaceutical Co
|
MEROPENEM INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg mg
|
MEROPENEM INJECTION, POWDER, FOR SOLUTION PARENTERAL 500 mg
|
MEROPENEM
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
MELOXICAM-SHAFA TABLET ORAL 7.5 mg
|
MELOXICAM TABLET ORAL 7.5 mg
|
MELOXICAM
|
M01AC06
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Oxicams
|
meloxicam
|
Zagros Darou Parsian
|
ACETAMINOPHEN/CODEINE TABLET ORAL 300 mg/20 mg
|
ACETAMINOPHEN / CODEINE PHOSPHATE TABLET ORAL 300 mg/20 mg
|
ACETAMINOPHEN / CODEINE PHOSPHATE
|
N02BE71
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol, combinations with psycholeptics
|
Dorsa darou
|
GABAPENTIN CAPSULE ORAL 300 mg
|
GABAPENTIN CAPSULE ORAL 300 mg
|
GABAPENTIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pursina Pharmaceutical Co.
|
SIMVASTATIN TABLET ORAL 20 mg
|
SIMVASTATIN TABLET ORAL 20 mg
|
SIMVASTATIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
LICADINE-P CREAM TOPICAL 2.5 %/2.5 % 30 g
|
LIDOCAINE / PRILOCAINE CREAM TOPICAL 2.5 %/2.5 % 30 g
|
LIDOCAINE / PRILOCAINE
|
N01BB52
|
NERVOUS SYSTEM
|
ANESTHETICS
|
ANESTHETICS, LOCAL
|
Amides
|
lidocaine, combinations
|
Avicenna Laboratories Inc.
|
ACICLOVIR TABLET ORAL 200 mg
|
ACICLOVIR TABLET ORAL 200 mg
|
ACICLOVIR
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
null |
OSVE-VITAMIN D3® 300,000U/1ML AMP INJECTION PARENTERAL 300000 [iU]/1mL
|
VITAMIN D3 INJECTION PARENTERAL 300000 [iU]/1mL
|
VITAMIN D3
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pakdarou Pharmaceutical Company
|
PEDIATRIC GRIPPE PAKDAROU SYRUP ORAL 0.67 mg/10 mg/5mL 60 mL
|
PEDIATRIC GRIPPE SYRUP ORAL 0.67 mg/10 mg/5mL 60 mL
|
PEDIATRIC GRIPPE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aryapharmaceutical
|
ARYAFEN CAPSULE ORAL 325 mg/40 mg/200 mg
|
ACETAMINOPHEN / CAFFEINE / IBUPROFEN CAPSULE ORAL 325 mg/40 mg/200 mg
|
ACETAMINOPHEN / CAFFEINE / IBUPROFEN
|
N02BE71
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol, combinations with psycholeptics
|
Sobhandarou
|
IMIPRAMINE TABLET ORAL 25 mg
|
IMIPRAMINE HYDROCHLORIDE TABLET ORAL 25 mg
|
IMIPRAMINE HYDROCHLORIDE
|
N06AA02
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTIDEPRESSANTS
|
Non-selective monoamine reuptake inhibitors
|
imipramine
|
Zydus Oncosciences
|
BIONASE INJECTION, POWDER, FOR SOLUTION PARENTERAL 10000 [iU] [iU]
|
ASPARAGINASE INJECTION, POWDER, FOR SOLUTION PARENTERAL 10000 [iU]
|
ASPARAGINASE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
NAPROXEN SUPPOSITORY RECTAL 500 mg
|
NAPROXEN SUPPOSITORY RECTAL 500 mg
|
NAPROXEN
|
M01AE02
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Propionic acid derivatives
|
naproxen
|
Toliddaru Pharma. Co.
|
GAYOL SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN
|
R05CA03
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
|
Expectorants
|
guaifenesin
|
Aani darman pharmaceutical Co.
|
AZITHROMYCIN CAPSULE ORAL 500 mg
|
AZITHROMYCIN CAPSULE ORAL 500 mg
|
AZITHROMYCIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pakdarou Pharmaceutical Company
|
ERYTHROMYCIN PAKDAROU SOLUTION TOPICAL 4 % 60 mL
|
ERYTHROMYCIN SOLUTION TOPICAL 4 % 60 mL
|
ERYTHROMYCIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Mehr Darou
|
NEUROPENTIN CAPSULE ORAL 100 mg
|
GABAPENTIN CAPSULE ORAL 100 mg
|
GABAPENTIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Razak Labratories
|
PIROXICAM CAPSULE ORAL 10 mg
|
PIROXICAM CAPSULE ORAL 10 mg
|
PIROXICAM
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Loghman Pharmaceutical & Hygienic (public)
|
CEFAZOLIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g g
|
CEFAZOLIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g
|
CEFAZOLIN
|
J01DB04
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
OTHER BETA-LACTAM ANTIBACTERIALS
|
First-generation cephalosporins
|
cefazolin
|
Farabi Pharmaceutical
|
FAREXIME POWDER, FOR SUSPENSION ORAL 100 mg/5 mL 50 mL
|
CEFIXIME POWDER, FOR SUSPENSION ORAL 100 mg/5 mL 50 mL
|
CEFIXIME
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
KETOTIFEN SYRUP ORAL 1 mg/5mL 60 mL
|
KETOTIFEN SYRUP ORAL 1 mg/5mL 60 mL
|
KETOTIFEN
|
R06AX17
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Other antihistamines for systemic use
|
ketotifen
|
Sina Darou Laboratories
|
NEOPHRIN SOLUTION, DROPS OPHTHALMIC 5 % 10 mL
|
PHENYLEPHRINE HYDROCHLORIDE SOLUTION, DROPS OPHTHALMIC 5 % 10 mL
|
PHENYLEPHRINE HYDROCHLORIDE
|
S01GA55
|
SENSORY ORGANS
|
OPHTHALMOLOGICALS
|
DECONGESTANTS AND ANTIALLERGICS
|
Sympathomimetics used as decongestants
|
phenylephrine, combinations
|
Darou Pakhsh
|
DEXTROSE/SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 3.33 %/0.3 % 1000 mL
|
DEXTROSE / SODIUM CHLORIDE INJECTION, SOLUTION INTRAVENOUS 3.33 %/0.3 % 1000 mL
|
DEXTROSE / SODIUM CHLORIDE
|
B05BB02
|
BLOOD AND BLOOD FORMING ORGANS
|
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
|
I.V. SOLUTIONS
|
Solutions affecting the electrolyte balance
|
electrolytes with carbohydrates
|
Sina Darou Laboratories
|
BETASONATE OINTMENT OPHTHALMIC 0.1 % 3 g
|
BETAMETHASONE (AS DISODIUM PHOSPHATE) OINTMENT OPHTHALMIC 0.1 % 3 g
|
BETAMETHASONE (AS DISODIUM PHOSPHATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Farabi Pharmaceutical
|
AMPICILLIN CAPSULE ORAL 500 mg
|
AMPICILLIN CAPSULE ORAL 500 mg
|
AMPICILLIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Alborzdarou
|
ASA TABLET ORAL 325 mg
|
ASA (ACETYLSALICYLIC ACID) TABLET ORAL 325 mg
|
ASA (ACETYLSALICYLIC ACID)
|
N02BA01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Salicylic acid and derivatives
|
acetylsalicylic acid
|
Razak Labratories
|
NAPROXEN TABLET ORAL 250 mg
|
NAPROXEN TABLET ORAL 250 mg
|
NAPROXEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Bakhtar Bioshimi
|
BIODOPAX-B TABLET ORAL 100 mg/25 mg
|
LEVODOPA / BENSERAZIDE TABLET ORAL 100 mg/25 mg
|
LEVODOPA / BENSERAZIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
FERTIGEST SUPPOSITORY VAGINAL 400 mg
|
PROGESTERONE SUPPOSITORY VAGINAL 400 mg
|
PROGESTERONE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Cosar Pharmaceutical
|
IRAMOX POWDER, FOR SUSPENSION ORAL 125 mg/5mL 100 mL
|
AMOXICILLIN POWDER, FOR SUSPENSION ORAL 125 mg/5mL 100 mL
|
AMOXICILLIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Bioindustria L.i.m. S.p.a.
|
AMIODARONE BIOINDUSTRIA L.I.M INJECTION PARENTERAL 50 mg/1 mL 3 mg
|
AMIODARONE HYDROCHLORIDE INJECTION PARENTERAL 50 mg/1 mL 3 mL
|
AMIODARONE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
ZEPROL TABLET ORAL 5 mg
|
BISOPROLOL FUMARATE TABLET ORAL 5 mg
|
BISOPROLOL FUMARATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Jalinous Pharmaceutical Co.
|
DOMPERIDONE-JALINOUS TABLET ORAL 10 mg
|
DOMPERIDONE TABLET ORAL 10 mg
|
DOMPERIDONE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
TRIFARBE TABLET ORAL
|
CONTRACEPTIVE TRIPHASIC TABLET ORAL
|
CONTRACEPTIVE TRIPHASIC
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
THIORIDAZINE TABLET ORAL 25 mg
|
THIORIDAZINE HYDROCHLORIDE TABLET ORAL 25 mg
|
THIORIDAZINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
ONDANIL TABLET ORAL 4 mg
|
ONDANSETRON TABLET ORAL 4 mg
|
ONDANSETRON
|
A04AA01
|
ALIMENTARY TRACT AND METABOLISM
|
ANTIEMETICS AND ANTINAUSEANTS
|
ANTIEMETICS AND ANTINAUSEANTS
|
Serotonin (5HT3) antagonists
|
ondansetron
|
Avicenna Laboratories Inc.
|
AVISIROX TABLET ORAL 180 mg
|
DEFERASIROX TABLET ORAL 180 mg
|
DEFERASIROX
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
VITAMIN B12 INJECTION PARENTERAL 1000 ug/1mL mL
|
VITAMIN B12 INJECTION PARENTERAL 1000 ug/1mL
|
VITAMIN B12
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
BETAMETHASONE SOLUTION, DROPS OPHTHALMIC 0.1 % 5 mL
|
BETAMETHASONE (AS DISODIUM PHOSPHATE) SOLUTION, DROPS OPHTHALMIC 0.1 % 5 mL
|
BETAMETHASONE (AS DISODIUM PHOSPHATE)
|
S03
|
SENSORY ORGANS
|
OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
| null | null | null |
Jalinous Pharmaceutical Co.
|
VALSARTAN TABLET ORAL 160 mg
|
VALSARTAN TABLET ORAL 160 mg
|
VALSARTAN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Daana Pharma
|
CEFALEXIN POWDER, FOR SUSPENSION ORAL 125 mg/5mL 100 g
|
CEFALEXIN POWDER, FOR SUSPENSION ORAL 125 mg/5mL 100 mL
|
CEFALEXIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
CIPROFLOXACIN TABLET ORAL 750 mg
|
CIPROFLOXACIN (AS HYDROCHLORIDE) TABLET ORAL 750 mg
|
CIPROFLOXACIN (AS HYDROCHLORIDE)
|
J01MA02
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
ciprofloxacin
|
Amin Pharmaceutical Co.
|
DICYCLOMINE ELIXIR ORAL 10 mg/5mL 60 mL
|
DICYCLOMINE HYDROCHLORIDE ELIXIR ORAL 10 mg/5mL 60 mL
|
DICYCLOMINE HYDROCHLORIDE
|
A03AA07
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
Synthetic anticholinergics, esters with tertiary amino group
|
dicycloverine
|
Jalinous Pharmaceutical Co.
|
CARBAMAZEPINE-JALINOUS TABLET ORAL 200 mg
|
CARBAMAZEPINE TABLET ORAL 200 mg
|
CARBAMAZEPINE
|
N03AF01
|
NERVOUS SYSTEM
|
ANTIEPILEPTICS
|
ANTIEPILEPTICS
|
Carboxamide derivatives
|
carbamazepine
|
Sepidaj Pharmaceutical Company
|
DILICE LOTION TOPICAL 4 % 60 mL
|
DIMETHICONE LOTION TOPICAL 4 % 60 mL
|
DIMETHICONE
|
D02AA
|
DERMATOLOGICALS
|
EMOLLIENTS AND PROTECTIVES
|
EMOLLIENTS AND PROTECTIVES
|
Silicone products
| null |
Aburaihan Pharmaceutical Co
|
ACETAMINOPHEN INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 150 mg/1mL 6.7 mL
|
ACETAMINOPHEN INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 150 mg/1mL 6.7 mL
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Tehran Chemie Pharmaceutical Co.
|
ROSUTEX TABLET ORAL 10 mg
|
ROSUVASTATIN (AS CALCIUM) TABLET ORAL 10 mg
|
ROSUVASTATIN (AS CALCIUM)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
DICLOKIM TABLET, DELAYED RELEASE ORAL 25 mg
|
DICLOFENAC SODIUM TABLET, DELAYED RELEASE ORAL 25 mg
|
DICLOFENAC SODIUM
|
M01AB05
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
diclofenac
|
Kishmedipharm
|
MEGAFEN CAPSULE ORAL 325 mg/40 mg/200 mg
|
ACETAMINOPHEN / CAFFEINE / IBUPROFEN CAPSULE ORAL 325 mg/40 mg/200 mg
|
ACETAMINOPHEN / CAFFEINE / IBUPROFEN
|
N02BE71
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol, combinations with psycholeptics
|
Shahre Daru
|
PRASUGREL TABLET ORAL 5 mg
|
PRASUGREL TABLET ORAL 5 mg
|
PRASUGREL
|
B01AC22
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTITHROMBOTIC AGENTS
|
ANTITHROMBOTIC AGENTS
|
Platelet aggregation inhibitors excl. heparin
|
prasugrel
|
Fanavarihaye Novin Darouie Atieh
|
CHLORPROMAZINE TABLET ORAL 100 mg
|
CHLORPROMAZINE HYDROCHLORIDE TABLET ORAL 100 mg
|
CHLORPROMAZINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Avicenna Laboratories Inc.
|
AVILUKAST TABLET ORAL 10 mg
|
MONTELUKAST TABLET ORAL 10 mg
|
MONTELUKAST
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Chemidarou
|
NAPROXEN TABLET, DELAYED RELEASE ORAL 500 mg
|
NAPROXEN TABLET, DELAYED RELEASE ORAL 500 mg
|
NAPROXEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
CLOZAM TABLET ORAL 10 mg
|
CLOBAZAM TABLET ORAL 10 mg
|
CLOBAZAM
|
N05BA09
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANXIOLYTICS
|
Benzodiazepine derivatives
|
clobazam
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
LIPOFIX TABLET ORAL 10 mg
|
ATORVASTATIN (AS CALCIUM) TABLET ORAL 10 mg
|
ATORVASTATIN (AS CALCIUM)
|
C10AA05
|
CARDIOVASCULAR SYSTEM
|
LIPID MODIFYING AGENTS
|
LIPID MODIFYING AGENTS, PLAIN
|
HMG CoA reductase inhibitors
|
atorvastatin
|
Tehran Chemie Pharmaceutical Co.
|
HISOMIN TABLET ORAL 180 mg
|
FEXOFENADINE HYDROCHLORIDE TABLET ORAL 180 mg
|
FEXOFENADINE HYDROCHLORIDE
|
R06AX26
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Other antihistamines for systemic use
|
fexofenadine
|
Jaber Ebne Hayyan
|
NISTAT POWDER, FOR SUSPENSION ORAL 100000 [iU]/1mL mL
|
NYSTATIN POWDER, FOR SUSPENSION ORAL 100000 [iU]/1mL
|
NYSTATIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
FLUCONAZOLE CAPSULE ORAL 50 mg
|
FLUCONAZOLE CAPSULE ORAL 50 mg
|
FLUCONAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
TIDI FLU SYRUP ORAL 125 mg/50 mg/2.5 mg/5mL 120 mL
|
ACETAMINOPHEN / GUAIFENESIN / PHENYLEPHRINE SYRUP ORAL 125 mg/50 mg/2.5 mg/5mL 120 mL
|
ACETAMINOPHEN / GUAIFENESIN / PHENYLEPHRINE
|
R05X
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
OTHER COLD PREPARATIONS
| null | null |
Avicenna Laboratories Inc.
|
PANTOPRAZOLE CAPSULE, DELAYED RELEASE ORAL 40 mg
|
PANTOPRAZOLE CAPSULE, DELAYED RELEASE ORAL 40 mg
|
PANTOPRAZOLE
|
A02BC02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
pantoprazole
|
Emad Darman Pars
|
IBUPROFEN-EMAD SUSPENSION ORAL 100 mg/5mL 120 mL
|
IBUPROFEN SUSPENSION ORAL 100 mg/5mL 120 mL
|
IBUPROFEN
|
M01AE01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Propionic acid derivatives
|
ibuprofen
|
Toliddaru Pharma. Co.
|
LEVOFLOXACIN TABLET ORAL 500 mg
|
LEVOFLOXACIN TABLET ORAL 500 mg
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Dr. Abidi Pharmaceuticals
|
LANZO ABIDI CAPSULE, DELAYED RELEASE ORAL 30 mg
|
LANSOPRAZOLE CAPSULE, DELAYED RELEASE ORAL 30 mg
|
LANSOPRAZOLE
|
A02BC03
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
lansoprazole
|
Cinnagen Co.
|
CINNOMER (AUTO INJECTOR) INJECTION, SOLUTION PARENTERAL 40 mg/1mL mL
|
GLATIRAMER ACETATE INJECTION, SOLUTION PARENTERAL 40 mg/1mL
|
GLATIRAMER ACETATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
VENUSTATE CAPSULE ORAL 120 mg
|
ORLISTAT CAPSULE ORAL 120 mg
|
ORLISTAT
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Boehringer Ingelheim
|
SPIRIVA CAPSULE RESPIRATORY 18 ug
|
TIOTROPIUM (AS BROMIDE) CAPSULE RESPIRATORY 18 ug
|
TIOTROPIUM (AS BROMIDE)
|
R03BB04
|
RESPIRATORY SYSTEM
|
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
|
Anticholinergics
|
tiotropium bromide
|
Tehran Darou Pharmaceutical Co.
|
LETANEX TABLET ORAL 500 mg
|
LEVOFLOXACIN TABLET ORAL 500 mg
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Mehr Darou
|
FOLIC ACID TABLET ORAL 5 mg
|
FOLIC ACID TABLET ORAL 5 mg
|
FOLIC ACID
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Aburaihan Pharmaceutical Co
|
ONDANIL INJECTION PARENTERAL 2 mg/1 mL 2 mL
|
ONDANSETRON INJECTION PARENTERAL 2 mg/1 mL 2 mL
|
ONDANSETRON
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Chemidarou
|
TRIFLUOPERAZINE INJECTION INTRAMUSCULAR 1 mg/1mL mL
|
TRIFLUOPERAZINE INJECTION INTRAMUSCULAR 1 mg/1mL
|
TRIFLUOPERAZINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
RELICOL TABLET ORAL 325 mg/5 mg/2 mg
|
ACETAMINOPHEN / PHENYLEPHRINE / CHLORPHENIRAMINE TABLET ORAL 325 mg/5 mg/2 mg
|
ACETAMINOPHEN / PHENYLEPHRINE / CHLORPHENIRAMINE
|
R05X
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
OTHER COLD PREPARATIONS
| null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.